Toll-like receptor modulators: a patent review (2006 –– 2010)

Author： Basith Shaherin   Manavalan Balachandran   Lee Gwang   Kim Sang Geon   Choi Sangdun  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.21, Iss.6, 2011-06, pp. : 927-944

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Toll-like receptor agonists: a patent review (2011 – 2013)

By Hussein Waleed M   Liu Tzu-Yu   Skwarczynski Mariusz   Toth Istvan  

Expert Opinion on Therapeutic Patents, Vol. 24, Iss. 4, 2014-04 ,pp. : 453-470

Informa Healthcare

Access to resources Recommend Favorite

AMP-activated protein kinase modulators: a patent review (2006 –– 2010)

By Yun Hee   Ha Joohun  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 7, 2011-07 ,pp. : 983-1005

Informa Healthcare

Access to resources Recommend Favorite

Farnesyl pyrophosphate synthase modulators: a patent review (2006 – 2010)

By Sun Shuting   McKenna Charles E  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 9, 2011-09 ,pp. : 1433-1451

Informa Healthcare

Access to resources Recommend Favorite

Tachykinin NK2 receptor antagonists. A patent review (2006 – 2010)

By Altamura Maria  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 1, 2012-01 ,pp. : 57-77

Informa Healthcare

Access to resources Recommend Favorite

Sigma receptor modulators: a patent review

By Collina Simona   Gaggeri Raffaella   Marra Annamaria   Bassi Andrea   Negrinotti Sara   Negri Francesca   Rossi Daniela  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 5, 2013-05 ,pp. : 597-613

Informa Healthcare

Access to resources Recommend Favorite